UroGen Pharma URGN Price Prediction

The determination to procure UroGen Pharma is entirely contingent on your individualistic risk tolerance. As you may discern, UroGen Pharma's value has experienced a fall of -0.69% during the preceding 24 hours, and UroGen Pharma has incurred a growth of 16.96% over the prior 30-day duration. Consequently, the determination of whether or not to invest in UroGen Pharma will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of UroGen Pharma may potentially surge to $30.17 by the end of this year. Looking at UroGen Pharma's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $28.45. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental UroGen Pharma forecast, the price of UroGen Pharma will fall by -1.8% over the next week and reach $22.75 by January 23, 2026.

Based on the our new experimental UroGen Pharma forecast, the price of UroGen Pharma will increase by 3.7% over the next month and reach $24.03 by February 15, 2026.

As per our most recent prediction on UroGen Pharma's value in 2026, URGN is anticipated to fluctuate within the range of $22.75 and $30.17. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected UroGen Pharma price forecast fails to consider sudden and extreme price fluctuations.

UroGen Pharma's future appears to be on an upward trend, with an maximum price of $28.45 projected after a period of five years. Based on the UroGen Pharma forecast for 2031, UroGen Pharma's value may potentially reach its highest peak of approximately $28.45, while its lowest peak is anticipated to be around $25.62.

Based on the our new experimental UroGen Pharma price prediction simulation, URGN’s value in 2026 expected to grow by 30.23% to $30.17 if the best happened. The price will be between $30.17 and $22.75 during 2026.

According to our latest experimental simulation for UroGen Pharma price prediction, URGN’s value could rise by 36.75% to $31.68 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $31.68 and $24.86 throughout the year.

Our new experimental UroGen Pharma price prediction model suggests that URGN’s value in 2028 could increase by 13.66% , reaching $26.33 in the best-case scenario. The price is expected to range between $26.33 and $19.52 during the year.

Based on our experimental forecast model, UroGen Pharma's value may experience a 1.21% growth in 2029, potentially reaching $23.45 under optimal conditions. The predicted price range for 2029 lies between $23.45 and $19.68.

Using our new experimental simulation for UroGen Pharma price predictions, URGN’s value in 2030 is expected to rise by 18.96% , reaching $27.56 in the best scenario. The price is forecasted to range between $27.56 and $20.83 over the course of 2030.

Our experimental simulation indicates that UroGen Pharma’s price could grow by 22.79% in 2031, potentially hitting $28.45 under ideal conditions. The price will likely fluctuate between $28.45 and $25.62 during the year.

Based on the findings from our latest experimental UroGen Pharma price prediction, URGN could see a 46.11% rise in value, reaching $33.85 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $33.85 and $27.68 throughout the year.

According to our experimental UroGen Pharma price prediction, URGN’s value is anticipated to rise by 84.81% in 2033, with the highest potential price being $42.82. Throughout the year, URGN’s price could range from $42.82 and $33.92.

The results from our new UroGen Pharma price prediction simulation suggest that URGN may rise by 112.3% in 2034, potentially reaching $49.19 under the best circumstances. The predicted price range for the year is between $49.19 and $41.41.

Based on our experimental forecast for UroGen Pharma’s price, URGN could grow by 163.32% , with the value potentially hitting $61.01 in 2035. The expected price range for the year lies between $61.01 and $46.38.

Our recent UroGen Pharma price prediction simulation suggests that URGN’s value might rise by 259.64% in 2036, possibly reaching $83.32 if conditions are optimal. The expected price range for 2036 is between $83.32 and $58.08.

According to the experimental simulation, UroGen Pharma’s value could rise by 356.83% in 2037, with a high of $105.84 under favorable conditions. The price is expected to fall between $105.84 and $81.88 over the course of the year.